Remove Document Remove Documentation Remove Packaging
article thumbnail

FDA guidance highlights E&L considerations for ophthalmic drug products

European Pharmaceutical Review

This document is revised from a version published in October 2023. Firstly, leachables can compromise a products quality and therapeutic effect, by potentially interacting with the formulated drug product, the document reported. Moreover, manufacturers should document information about their safety thresholds, the guidance stated.

article thumbnail

How to implement good documentation practice in a GMP regulated plant

GMPSOP

Table of Contents Good documentation practice requires a system for control, implementation, maintenance and archival of GMP related documents and records. To implement good documentation practice and systems the site must assure that GMP documents and records are adequate, approved and in compliance with applicable GMP requirements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

Of the cGMP letters, three major types of violations – deficiencies in process validation, documentation practices (data integrity) and quality control – accounted for 26 percent, 21 percent and 15 percent of warning letters respectively. Overall, validation, documentation and quality control were the major cGMP violations.

article thumbnail

USP General Chapter —Glass revised

European Pharmaceutical Review

In response to supply chain challenges, including shortages of critical glass vials for products like COVID-19 vaccines and parenteral drugs, the Packaging and Distribution Expert Committee (PD EC) has made a significant revision of United States Pharmacopeia (USP) General Chapter <660>—Glass.

Packaging 105
article thumbnail

Bharat Parenterals Limited-Openings for Freshers & Experienced in Regulatory Affairs Dept. -Apply Now

Pharma Pathway

-Apply Now @ Bharat Parenterals Limited Department : Regulatory Affairs Qualification: M.Pharm Designation: Officer/ Officer/ Executive/ Senior Executive Experience: 02 to 05 years (Freshers can also Apply) Job Responsibilities: Responsible for Dossier & Documents preparation. Review of the dossiers, DMF & Technical documents.

article thumbnail

FedEx Life Science Center launched in Mumbai

Express Pharma

The post FedEx Life Science Center launched in Mumbai appeared first on Express Pharma.

article thumbnail

Chandigarh Calling!

Express Pharma

Proper documentation and effective data management were underscored as essential elements in building and sustaining a culture of quality and compliance within the industry. Embracing innovation in pharma packaging is vital become future Shivaji Chakraborty, Asst.

Packaging 104